FDA Gives Clinical Trial Green Light On Drug To Treat Alzheimer's Disease (Medical News Today)
The Food and Drug Administration (FDA) has given the Blanchette Rockefeller Neurosciences Institute (BRNI) the go-ahead to conduct Phase II clinical trials of Bryostatin for the treatment of Alzheimer's disease patients. The drug showed pre-clinical efficacy to not only treat Alzheimer's disease symptoms, but also its underlying causes.

FDA To Allow Sale Of Plan B Emergency Contraception To 17-Year-Olds (Medical News Today)
FDA on Wednesday announced that it will allow the non-prescription sale of the emergency contraceptive Plan B to individuals ages 17 years and older, in compliance with a federal judge's March 23 ruling that the agency's 2006 decision to limit access to women ages 18 and older was politically motivated and scientifically flawed, the Washington Post reports. U.S.